A recent study suggests that patients who stop using blockbuster slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who halt conventional lifestyle regimens.
Published data in a major medical journal shows that while obese individuals often shed about a fifth of their total mass while using the jabs, the weight returns at an estimated rate of nearly a kilo each month once they quit.
"Individuals purchasing these medications must be informed of the potential of rapid weight regain when the medication is stopped," warns researcher Dr. Susan Jebb.
That rate of recovery implies a return to pre-treatment weight within about 18 months.
Weighing Treatments
The study, which reviewed dozens of trials involving over 9,000 of participants, contrasted the outcomes of GLP-1 agonists with other pills.
Researchers point out that individuals who lose weight through lifestyle changes alone generally see a slower weight regain—perhaps 100 grams monthly—post-intervention.
Explaining the Quick Rebound
Doctors propose the mechanism of the jabs is key to understanding the heightened rebound.
These medications imitate a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Artificially providing the hormone levels several times higher than the body's typical production might result in the body to generate a reduced amount of its endogenous GLP-1, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.
"Stopping of this medication leads to hunger is no longer kept in check, making overeating far more likely."
A Chronic Condition?
The NHS suggest the injections for people with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
Professionals contend that, due to the significant potential of weight regain, the treatment is often ongoing.
This perspective is echoed by drug manufacturers, who say that the results "emphasize the long-term character of excess weight," similar to managing conditions like diabetes.
Patient Testimonies
Users who have stopped the jabs describe a intense resurgence of hunger.
"It was like a trigger flipping and you're instantly extremely hungry," described a patient.
The struggle is worsened if users have not adopted permanent dietary or behavioural changes during therapy.
Significant Use
Survey data indicate that a significant number of adults in the UK have used weight-loss jabs in the past year, with desire continuing to grow.
- Use is higher among females than males.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion obtain the drugs through private healthcare rather than public health services.
Ultimately, researchers emphasize that while the jabs are effective agents for shedding pounds, they are not a magic cure and maintained weight loss relies on integrated lifestyle management.
